Glycosylation pattern of anti-platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia

British Journal of Haematology

Volumn 174, Issue 2, 2016, Pages 310-320

  Sonneveld, Myrthe E ^a   Natunen, Suvi ^b   Sainio, Susanna ^b   Koeleman, Carolien A M ^c   Holst, Stephanie ^c   Dekkers, Gillian ^a   Koelewijn, Joke ^a   Partanen, Jukka ^b   van der Schoot, C Ellen ^a   Wuhrer, Manfred ^c   Vidarsson, Gestur ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b FINNISH RED CROSS BLOOD SERVICE   (Finland)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alloantibodies; Fc fucosylation; Fc glycosylation; Fetal or neonatal alloimmune thrombocytopenia; Immunology

Indexed keywords

ERYTHROCYTE ANTIGEN; FC GAMMA RIIIA; FC GAMMA RIIIB; FC RECEPTOR; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; THROMBOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN SPECIFICITY; ARTICLE; CHEMICAL MODIFICATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEASIBILITY STUDY; FEMALE; FETUS; FUCOSYLATION; GALACTOSYLATION; HUMAN; LONGITUDINAL STUDY; MASS SPECTROMETRY; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; OUTCOME ASSESSMENT; PREDICTION; PREGNANCY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; SIALYLATION;

EID: 84978176813     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.14053     Document Type: Article

References (50)

1. Ackerman, M.E., Crispin, M., Yu, X., Baruah, K., Boesch, A.W., Harvey, D.J., Dugast, A.S., Heizen, E.L., Ercan, A., Choi, I., Streeck, H., Nigrovic, P.A., Bailey-Kellogg, C., Scanlan, C. & Alter, G. (2013) Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. Journal of Clinical Investigation, 123, 2183–2192.
2. Allen, D., Rigsby, P., Bessos, H., Berry, J., Wilson, D., Ouwehand, W.H., Urbaniak, S. & Metcalfe, P. (2005) Collaborative study to establish the first international standard for quantitation of anti-HPA-1a. Vox Sanguinis, 89, 100–104.
3. Anthony, R.M., Nimmerjahn, F., Ashline, D.J., Reinhold, V.N., Paulson, J.C. & Ravetch, J.V. (2008) Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science, 320, 373–376.
4. Arnold, J.N., Wormald, M.R., Sim, R.B., Rudd, P.M. & Dwek, R.A. (2007) The impact of glycosylation on the biological function and structure of human immunoglobulins. Annual Review of Immunology, 25, 21–50.
5. Bakchoul, T., Kubiak, S., Krautwurst, A., Roderfeld, M., Siebert, H.C., Bein, G., Sachs, U.J. & Santoso, S. (2011) Low-avidity anti-HPA-1a alloantibodies are capable of antigen-positive platelet destruction in the NOD/SCID mouse model of alloimmune thrombocytopenia. Transfusion, 51, 2455–2461.
6. Bakchoul, T., Bertrand, G., Krautwurst, A., Kroll, H., Bein, G., Sachs, U.J., Santoso, S. & Kaplan, C. (2013) The implementation of surface plasmon resonance technique in monitoring pregnancies with expected fetal and neonatal alloimmune thrombocytopenia. Transfusion, 53, 2078–2085.
7. Bakovic, M.P., Selman, M.H., Hoffmann, M., Rudan, I., Campbell, H., Deelder, A.M., Lauc, G. & Wuhrer, M. (2013) High-throughput IgG Fc N-glycosylation profiling by mass spectrometry of glycopeptides. Journal of Proteome Research, 12, 821–831.
8. Bertrand, G., Drame, M., Martageix, C. & Kaplan, C. (2011) Prediction of the fetal status in noninvasive management of alloimmune thrombocytopenia. Blood, 117, 3209–3213.
9. Bertrand, G., Bakchoul, T., Javela, K., Kjaer, K.M. & Kaplan, C. (2012) Interlaboratory workshop on anti-HPA-1a alloantibody quantification with the mAb-specific immobilization of platelet antigen technique. Journal of Thrombosis and Haemostasis, 10, 1172–1174.
10. Bondt, A., Selman, M.H., Deelder, A.M., Hazes, J.M., Willemsen, S.P., Wuhrer, M. & Dolhain, R.J. (2013) Association between galactosylation of immunoglobulin G and improvement of rheumatoid arthritis during pregnancy is independent of sialylation. Journal of Proteome Research, 12, 4522–4531.
11. Bondt, A., Rombouts, Y., Selman, M.H., Hensbergen, P.J., Reiding, K.R., Hazes, J.M., Dolhain, R.J. & Wuhrer, M. (2014) Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes. Molecular & Cellular Proteomics: MCP, 13, 3029–3039.
12. Campbell, I.K., Miescher, S., Branch, D.R., Mott, P.J., Lazarus, A.H., Han, D., Maraskovsky, E., Zuercher, A.W., Neschadim, A., Leontyev, D., McKenzie, B.S. & Kasermann, F. (2014) Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils. The Journal of Immunology, 192, 5031–5038.
13. Czajkowsky, D.M., Andersen, J.T., Fuchs, A., Wilson, T.J., Mekhaiel, D., Colonna, M., He, J., Shao, Z., Mitchell, D.A., Wu, G., Dell, A., Haslam, S., Lloyd, K.A., Moore, S.C., Sandlie, I., Blundell, P.A. & Pleass, R.J. (2015) Developing the IVIG biomimetic, hexa-Fc, for drug and vaccine applications. Scientific Reports, 5, 9526.
14. Ferrara, C., Grau, S., Jager, C., Sondermann, P., Brunker, P., Waldhauer, I., Hennig, M., Ruf, A., Rufer, A.C., Stihle, M., Umana, P. & Benz, J. (2011) Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose. Proceedings of the National Academy of Sciences of the United States of America, 108, 12669–12674.
15. van de Geijn, F.E., Wuhrer, M., Selman, M.H., Willemsen, S.P., de Man, Y.A., Deelder, A.M., Hazes, J.M. & Dolhain, R.J. (2009) Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study. Arthritis Research & Therapy, 11, R193.
16. Ghevaert, C., Campbell, K., Stafford, P., Metcalfe, P., Casbard, A., Smith, G.A., Allen, D., Ranasinghe, E., Williamson, L.M. & Ouwehand, W.H. (2007) HPA-1a antibody potency and bioactivity do not predict severity of fetomaternal alloimmune thrombocytopenia. Transfusion, 47, 1296–1305.
17. Guhr, T., Bloem, J., Derksen, N.I., Wuhrer, M., Koenderman, A.H., Aalberse, R.C. & Rispens, T. (2011) Enrichment of sialylated IgG by lectin fractionation does not enhance the efficacy of immunoglobulin G in a murine model of immune thrombocytopenia. PLoS One, 6, e21246.
18. Hodoniczky, J., Zheng, Y.Z. & James, D.C. (2005) Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro. Biotechnology Progress, 21, 1644–1652.
19. Houde, D., Peng, Y., Berkowitz, S.A. & Engen, J.R. (2010) Post-translational modifications differentially affect IgG1 conformation and receptor binding. Molecular & Cellular Proteomics: MCP, 9, 1716–1728.
20. Kamphuis, M.M., Paridaans, N., Porcelijn, L., de Haas, M., der van Schoot, C.E., Brand, A., Bonsel, G.J. & Oepkes, D. (2010) Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review. BJOG, 117, 1335–1343.
21. Kamphuis, M.M., Paridaans, N.P., Porcelijn, L., Lopriore, E. & Oepkes, D. (2014) Incidence and consequences of neonatal alloimmune thrombocytopenia: a systematic review. Pediatrics, 133, 715–721.
22. Kaneko, Y., Nimmerjahn, F. & Ravetch, J.V. (2006) Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science, 313, 670–673.
23. Kapur, R., Kustiawan, I., Vestrheim, A., Koeleman, C.A., Visser, R., Einarsdottir, H.K., Porcelijn, L., Jackson, D., Kumpel, B., Deelder, A.M., Blank, D., Skogen, B., Killie, M.K., Michaelsen, T.E., de Haas, M., Rispens, T., van der Schoot, C.E., Wuhrer, M. & Vidarsson, G. (2014a) A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy. Blood, 123, 471–480.
24. Kapur, R., Della, V.L., Sonneveld, M., Hipgrave, E.A., Visser, R., Ligthart, P., de Haas, M., Wuhrer, M., van der Schoot, C.E. & Vidarsson, G. (2014b) Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn. British Journal of Haematology, 166, 936–945.
25. Kapur, R., Zufferey, A., Boilard, E. & Semple, J.W. (2015a) Nouvelle cuisine: platelets served with inflammation. The Journal of Immunology, 194, 5579–5587.
26. Kapur, R., Della, V.L., Verhagen, O.J., Hipgrave, E.A., Ligthart, P., de Haas, M., Kumpel, B., Wuhrer, M., van der Schoot, C.E. & Vidarsson, G. (2015b) Prophylactic anti-D preparations display variable decreases in Fc-fucosylation of anti-D. Transfusion, 55, 553–562.
27. Kiefel, V., Santoso, S., Weisheit, M. & Mueller-Eckhardt, C. (1987) Monoclonal antibody–specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood, 70, 1722–1726.
28. Killie, M.K., Husebekk, A., Kjeldsen-Kragh, J. & Skogen, B. (2008) A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn. Haematologica, 93, 870–877.
29. Kjeldsen-Kragh, J., Killie, M.K., Tomter, G., Golebiowska, E., Randen, I., Hauge, R., Aune, B., Oian, P., Dahl, L.B., Pirhonen, J., Lindeman, R., Husby, H., Haugen, G., Gronn, M., Skogen, B. & Husebekk, A. (2007) A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia. Blood, 110, 833–839.
30. Kjeldsen-Kragh, J., Husebekk, A., Killie, M.K. & Skogen, B. (2008) Is it time to include screening for neonatal alloimmune thrombocytopenia in the general antenatal health care programme? Transfusion and Apheresis Sciences, 38, 183–188.
31. Kruijsen, D., Einarsdottir, H.K., Schijf, M.A., Coenjaerts, F.E., van der Schoot, E.C., Vidarsson, G. & van Bleek, G.M. (2013) Intranasal administration of antibody-bound respiratory syncytial virus particles efficiently primes virus-specific immune responses in mice. Journal of Virology, 87, 7550–7557.
32. Kumpel, B.M., Wang, Y., Griffiths, H.L., Hadley, A.G. & Rook, G.A. (1995) The biological activity of human monoclonal IgG anti-D is reduced by beta-galactosidase treatment. Human Antibodies and Hybridomas, 6, 82–88.
33. Lauc, G., Huffman, J.E., Pucic, M., Zgaga, L., Adamczyk, B., Muzinic, A., Novokmet, M., Polasek, O., Gornik, O., Kristic, J., Keser, T., Vitart, V., Scheijen, B., Uh, H.W., Molokhia, M., Patrick, A.L., McKeigue, P., Kolcic, I., Lukic, I.K., Swann, O., vanLeeuwen, F.N., Ruhaak, L.R., Houwing-Duistermaat, J.J., Slagboom, P.E., Beekman, M., deCraen, A.J., Deelder, A.M., Zeng, Q., Wang, W., Hastie, N.D., Gyllensten, U., Wilson, J.F., Wuhrer, M., Wright, A.F., Rudd, P.M., Hayward, C., Aulchenko, Y., Campbell, H. & Rudan, I. (2013) Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers. PLoS Genet, 9, e1003225.
34. Malhotra, R., Wormald, M.R., Rudd, P.M., Fischer, P.B., Dwek, R.A. & Sim, R.B. (1995) Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nature Medicine, 1, 237–243.
35. Mebius, R.E. & Kraal, G. (2005) Structure and function of the spleen. Nature Reviews Immunology, 5, 606–616.
36. Mizushima, T., Yagi, H., Takemoto, E., Shibata-Koyama, M., Isoda, Y., Iida, S., Masuda, K., Satoh, M. & Kato, K. (2011) Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans. Genes to Cells, 16, 1071–1080.
37. Pucic, M., Knezevic, A., Vidic, J., Adamczyk, B., Novokmet, M., Polasek, O., Gornik, O., Supraha-Goreta, S., Wormald, M.R., Redzic, I., Campbell, H., Wright, A., Hastie, N.D., Wilson, J.F., Rudan, I., Wuhrer, M., Rudd, P.M., Josic, D. & Lauc, G. (2011) High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations. Molecular & Cellular Proteomics: MCP, 10, M111.
38. Ruhaak, L.R., Uh, H.W., Deelder, A.M., Dolhain, R.E. & Wuhrer, M. (2014) Total plasma N-glycome changes during pregnancy. Journal of Proteome Research, 13, 1657–1668.
39. Sainio, S., Javela, K., Tuimala, J. & Koskinen, S. (2013) Usefulness of maternal anti-HPA-1a antibody quantitation in predicting severity of foetomaternal alloimmune thrombocytopenia. Transfusion Medicine (Oxford, England), 23, 114–120.
40. Selman, M.H., de Jong, S.E., Soonawala, D., Kroon, F.P., Adegnika, A.A., Deelder, A.M., Hokke, C.H., Yazdanbakhsh, M. & Wuhrer, M. (2012a) Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination. Molecular & Cellular Proteomics: MCP, 11, M111.
41. Selman, M.H., Derks, R.J., Bondt, A., Palmblad, M., Schoenmaker, B., Koeleman, C.A., van de Geijn, F.E., Dolhain, R.J., Deelder, A.M. & Wuhrer, M. (2012b) Fc specific IgG glycosylation profiling by robust nano-reverse phase HPLC-MS using a sheath-flow ESI sprayer interface. Journal of Proteomics, 75, 1318–1329.
42. Shibata-Koyama, M., Iida, S., Misaka, H., Mori, K., Yano, K., Shitara, K. & Satoh, M. (2009) Nonfucosylated rituximab potentiates human neutrophil phagocytosis through its high binding for FcgammaRIIIb and MHC class II expression on the phagocytotic neutrophils. Experimental Hematology, 37, 309–321.
43. Stadlmann, J., Weber, A., Pabst, M., Anderle, H., Kunert, R., Ehrlich, H.J., Peter, S.H. & Altmann, F. (2009) A close look at human IgG sialylation and subclass distribution after lectin fractionation. Proteomics, 9, 4143–4153.
44. Vestrheim, A.C., Moen, A., Egge-Jacobsen, W., Reubsaet, L., Halvorsen, T.G., Bratlie, D.B., Paulsen, B.S. & Michaelsen, T.E. (2014) A pilot study showing differences in glycosylation patterns of IgG subclasses induced by pneumococcal, meningococcal, and two types of influenza vaccines. Immunity, Inflammation and Disease, 2, 76–91.
45. Vidarsson, G., van der Pol, W.-L., van den Elsen, J.M.H., Vilé, H., Jansen, M., Duijs, J., Morton, H.C., Boel, E., Daha, M.R., Corthésy, B. & van de Winkel, J.G.J. (2001) Activity of human IgG and IgA subclasses in immune defense against Neisseria meningitidis serogroup B. The Journal of Immunology, 166, 6250–6256.
46. Vink, T., Oudshoorn-Dickmann, M., Roza, M., Reitsma, J.J. & de Jong, R.N. (2014) A simple, robust and highly efficient transient expression system for producing antibodies. Methods, 65, 5–10.
47. Wang, T.T., Maamary, J., Tan, G.S., Bournazos, S., Davis, C.W., Krammer, F., Schlesinger, S.J., Palese, P., Ahmed, R. & Ravetch, J.V. (2015) Anti-HA glycoforms drive B cell affinity selection and determine influenza vaccine efficacy. Cell, 162, 160–169.
48. Wuhrer, M., Stam, J.C., van de Geijn, F.E., Koeleman, C.A., Verrips, C.T., Dolhain, R.J., Hokke, C.H. & Deelder, A.M. (2007) Glycosylation profiling of immunoglobulin G (IgG) subclasses from human serum. Proteomics, 7, 4070–4081.
49. Wuhrer, M., Porcelijn, L., Kapur, R., Koeleman, C.A., Deelder, A., de Haas, M. & Vidarsson, G. (2009) Regulated glycosylation patterns of IgG during alloimmune responses against human platelet antigens. Journal of Proteome Research, 8, 450–456.
50. Zauner, G., Selman, M.H., Bondt, A., Rombouts, Y., Blank, D., Deelder, A.M. & Wuhrer, M. (2013) Glycoproteomic analysis of antibodies. Molecular & Cellular Proteomics: MCP, 12, 856–865.